Asia Deal Watch: Daiichi Sankyo Obtains Brazilian Rights To Mitsubishi Tanabe’s ALS Drug

 
• By Ian Haydock, Jung Won Shin, Joseph Haas, and Vibha Ravi

Daiichi Sankyo also gets right of first negotiation for edaravone, approved in the US and Japan, in other Central and South American markets. Astellas advances its “Rx+” strategy in partnership with iota Biosciences.

Shibuya, Tokyo, Japan crosswalk and cityscape. - Image
Two of Japan's largest pharmas team on marketing of edaravone

More from Deals

More from Business